European Respiratory Journal

The ERJ publishes clinical and experimental work relating to all aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine and thoracic surgery. In addition to original research material, the ERJ also publishes editorial commentaries, reviews, short research letters and correspondence to the editor. Articles are published continuously and collected into 12 monthly issues in two volumes per year.

March

Indications of BAL, lung biopsy, or both in mechanically ventilated patients with unexplained infiltrations Papazian L., Gainnier M. Eur Respir J 2003; 21: 383-384
Mechanical insufflation/exsufflation: has it come of age? A commentary Bach J.R. Eur Respir J 2003; 21: 385-386
A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-α Laan M., Prause O., Miyamoto M., Sjostrand M., Hytonen A.M., Kaneko T., Lotvall J., Linden A. Eur Respir J 2003; 21: 387-393
Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen Blesa S., Cortijo J., Mata M., Serrano A., Closa D., Santangelo F., Estrela J.M., Suchankova J., Morcillo E.J. Eur Respir J 2003; 21: 394-400
Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro Tsang K.W., Ng P., Ho P.L., Chan S., Tipoe G., Leung R., Sun J., Ho J.C., Ip M.S., Lam W.K. Eur Respir J 2003; 21: 401-406
Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis Ziegenhagen M.W., Rothe M.E., Schlaak M., Muller-Quernheim J. Eur Respir J 2003; 21: 407-413
Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach Sabounchi-Schutt F., Astrom J., Hellman U., Eklund A., Grunewald J. Eur Respir J 2003; 21: 414-420
Alveolar macrophages are the main source for tumour necrosis factor-α in patients with sarcoidosis Fehrenbach H., Zissel G., Goldmann T., Tschernig T., Vollmer E., Pabst R., Muller-Quernheim J. Eur Respir J 2003; 21: 421-428
Exhaled nitric oxide after lung transplantation: impact of the native lung Verleden G.M., Dupont L.J., Delcroix M., Van Raemdonck D., Vanhaecke J., Lerut T., Demedts M. Eur Respir J 2003; 21: 429-432
Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children Kharitonov S.A., Gonio F., Kelly C., Meah S., Barnes P.J. Eur Respir J 2003; 21: 433-438
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease Paredi P., Caramori G., Cramer D., Ward S., Ciaccia A., Papi A., Kharitonov S.A., Barnes P.J. Eur Respir J 2003; 21: 439-443
Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema Ferrarotti I., Zorzetto M., Beccaria M., Gile L.S., Porta R., Ambrosino N., Pignatti P.F., Cerveri I., Pozzi E., Luisetti M. Eur Respir J 2003; 21: 444-449
Predominant emphysema phenotype in chronic obstructive pulmonary disease patients Boschetto P., Miniati M., Miotto D., Braccioni F., De Rosa E., Bononi I., Papi A., Saetta M., Fabbri L.M., Mapp C.E. Eur Respir J 2003; 21: 450-454
Agreement between written and video questions for comparing asthma symptoms in ISAAC Crane J., Mallol J., Beasley R., Stewart A., Asher M.I. Eur Respir J 2003; 21: 455-461
Long-term mortality among adults with or without asthma in the PAARC study Vandentorren S., Baldi I., Annesi Maesano I., Charpin D., Neukirch F., Filleul L., Cantagrel A., Tessier J.F. Eur Respir J 2003; 21: 462-467
Long-term changes in adult asthma prevalence Brogger J., Bakke P., Eide G.E., Johansen B., Andersen A., Gulsvik A. Eur Respir J 2003; 21: 468-472
Bronchial asthma causing symptoms suggestive of angina pectoris Kiss D., Veegh W., Schragel D., Bachl C., Stollberger C., Sertl K. Eur Respir J 2003; 21: 473-477
Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment The Research Committee of the British Thoracic Society Eur Respir J 2003; 21: 478-482
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis Schon T., Elias D., Moges F., Melese E., Tessema T., Stendahl O., Britton S., Sundqvist T. Eur Respir J 2003; 21: 483-488
Combined bronchoalveolar lavage and transbronchial lung biopsy: safety and yield in ventilated patients Bulpa P.A., Dive A.M., Mertens L., Delos M.A., Jamart J., Evrard P.A., Gonzalez M.R., lnstalle E.J. Eur Respir J 2003; 21: 489-494
Bronchoalveolar lavage alterations during prolonged ventilation of patients without acute lung injury Tsangaris I., Lekka M.E., Kitsiouli E., Constantopoulos S., Nakos G. Eur Respir J 2003; 21: 495-501
Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness Chatwin M., Ross E., Hart N., Nickol A.H., Polkey M.I., Simonds A.K. Eur Respir J 2003; 21: 502-508
Blood pressure responsiveness to obstructive events during sleep after chronic CPAP Marrone O., Salvaggio A., Bonsignore M.R., Insalaco G., Bonsignore G. Eur Respir J 2003; 21: 509-514
The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea Mar J., Rueda J.R., Duran-Cantolla J., Schechter C., Chilcott J. Eur Respir J 2003; 21: 515-522
Ageing does not influence the sleep-related decrease in the hypercapnic ventilatory response Browne H.A.K., Adams L., Simonds A.K., Morrell M.J. Eur Respir J 2003; 21: 523-529
The pattern and timing of breathing during incremental exercise: a normative study Neder J.A., Dal Corso S., Malaguti C., Reis S., De Fuccio M.B., Schmidt H., Fuld J.P., Nery L.E. Eur Respir J 2003; 21: 530-538
Immunological mechanisms in pleural disease Antony V.B. Eur Respir J 2003; 21: 539-544
Pulmonary actinomycosis Mabeza G.F., Macfarlane J. Eur Respir J 2003; 21: 545-551
Organising pneumonia caused by transtuzumab (Herceptin) therapy for breast cancer Radzikowska E., Szczepulska E., Chabowski M., Bestry I. Eur Respir J 2003; 21: 552-555
The European Community Respiratory Health Survey II Knox J., Jarvis D., on behalf of the ... Eur Respir J 2003; 21: 556-560
From the Authors Walters E.H. Eur Respir J 2003; 21: 556
Chronic obstructive pulmonary disease: underdiagnosed, underinvestigated, inappropriately managed? Connolly C.K. Eur Respir J 2003; 21: 556-557
From the Authors Rennard S.I., Decramer M., Calverley P.M.A., Pride N.B., Soriano J.B., Vermeire P.A., Vestbo J. Eur Respir J 2003; 21: 557
Noninvasive ventilation in stable chronic obstructive pulmonary disease Kohnlein T., Welte T. Eur Respir J 2003; 21: 558
From the Authors Clini E., Ambrosino N. Eur Respir J 2003; 21: 558-559
Survival in COPD patients after regular use of fluticasone propionate and salmeterol Marchand E. Eur Respir J 2003; 21: 559-560
From the Authors Soriano J.B., Vestbo J., Pride N.B. Eur Respir J 2003; 21: 560
Public health and medicolegal implications of sleep apnoea. W.T. McNicholas and J. Krieger on behalf of the Task Force members. Eur Respir J 2003; 21: 561